Impact of Risk Minimisation Measures on Valproate Use among Women of Reproductive Age in Latvia Between 2013 and 2020: A 7-Year Nationwide Prescription Database Study.

Rutkovska, Ieva; Seilis, Andis; Neikena, Zane; Poplavska, Elita

Rutkovska, Ieva; Seilis, Andis; Neikena, Zane; Poplavska, Elita.

Afiliação

Rutkovska I; State Agency of Medicines of the Republic of Latvia, Jersikas Street 15, Riga, 1003, Latvia. ieva.rutkovska@zva.gov.lv.
Seilis A; Department of Applied Pharmacy, Faculty of Pharmacy, Riga Stradins University, Konsula Street 21, Riga, 1007, Latvia. ieva.rutkovska@zva.gov.lv.
Neikena Z; State Agency of Medicines of the Republic of Latvia, Jersikas Street 15, Riga, 1003, Latvia.
Poplavska E; State Agency of Medicines of the Republic of Latvia, Jersikas Street 15, Riga, 1003, Latvia.

Drugs Real World Outcomes ; 10(4): 639-649, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37821776

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google